RWM
DGX icon

Rialto Wealth Management’s Quest Diagnostics DGX Stock Holding History

Rialto Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.94K Buy
15
+4
+36% +$777 ﹤0.01% 735
2025
Q4 		$1.91K Buy
11
+2
+22% +$364 ﹤0.01% 763
2025
Q3 		$1.72K Buy
9
+2
+29% +$355 ﹤0.01% 711
2025
Q2 		$1.26K Buy
7
+4
+133% +$695 ﹤0.01% 753
2025
Q1 		$508 Buy
+3
New +$493 ﹤0.01% 829

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Rialto Wealth Management's DGX Position: Q1 2026 in Review

Rialto Wealth Management increased its Quest Diagnostics (DGX) stake by 36% in Q1 2026, buying an estimated $777 and bringing the position to 15 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Rialto Wealth Management first reported a position in DGX in Q1 2025 and has held it in 5 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Rialto Wealth Management held 15 shares of Quest Diagnostics worth $2.94K as of Q1 2026.
  • Rialto Wealth Management bought 4 Quest Diagnostics shares in Q1 2026, an estimated $777.
  • Quest Diagnostics made up ﹤0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #735 holding.
  • Rialto Wealth Management first reported a position in Quest Diagnostics in Q1 2025 and has held it in 5 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.